Rahiya Rehman

Dr. Rahiya Rehman

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2024 in Intestinal Research
Verified
Journal Article
Open access
PDF file
RRRahiya Rehman
Rahiya Rehman
MRMuhammad Safwan Riaz
Muhammad Safwan Riaz
DEDyadin Esharif
Dyadin Esharif
PHPhinnara Has
Phinnara Has
MHMichael Herzlinger
Michael Herzlinger
SSShova Subedi
Shova Subedi
Background/Aims: To describe the role of ustekinumab in inducing remission and endoscopic healing in anti-tumor necrosis factor α nonresponsive pediatric ulcerative colitis patients at a tertiary care inflammatory bowel disease center. Methods: A retrospective chart review was performed on patients with ulcerative colitis receiving ustekinumab. Primary outcome was steroidfree clinical remission at follow-up. Secondary outcomes were biochemical remission and endoscopic healing. Results: Ten children were analyzed; 7 (70%) had ulcerative colitis, and 3 (30%) had inflammatory bowel disease unspecified with colitis. Median follow-up period was 56 weeks. Nine patients (90%) achieved steroid-free clinical remission and biochemical remission. Seven patients had follow-up colonoscopies, out of which 6 (86%) achieved endoscopic remission, while 1 (14%) underwent colectomy. Out of the 3 patients without a follow-up colonoscopy, fecal calprotectin levels downtrended to < 150 mg/kg in 2 patients and < 400 mg/kg in 1 patient from baseline level of > 2,000 mg/kg. Conclusions: Ustekinumab appears efficacious in achieving not only clinical and biochemical remission but also has promising role in inducing endoscopic healing end point in patients who fail other biologics.

9 September 2025 in World Journal of Clinical Pediatrics
Verified
Journal Article
Open access
RRRahiya Rehman
Rahiya Rehman
This article examines the growing prevalence of pediatric obesity and its connection to metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents, focusing on the role of glucagon-like peptide-1 receptor agonists in treatment. Pediatric obesity and MASLD present significant long-term health risks, making early intervention crucial. The article reviews the pathophysiology of both pediatric obesity and MASLD, explores current therapeutic strategies, and discusses the emerging role of glucagon-like peptide-1 receptor agonists, such as liraglutide, semaglutide, exenatide, and dulaglutide, in managing obesity, as well as explores current limited pediatric literature on the use of these medications in MASLD.

1 May 2024 in Clinical Case Reports
Verified
Journal Article
Open access
RRRahiya Rehman
Rahiya Rehman
LGLeslia Gonzalez
Leslia Gonzalez
KKKelsey Kolbe
Kelsey Kolbe
MFMohammed Khurram Faizan
Mohammed Khurram Faizan
WBWilliam Brucker
William Brucker
CCCarolina Cerezo
Carolina Cerezo
Key Clinical Message: This current case series adds to the spectrum of Arthrogryposis renal dysfunction cholestasis (ARC)‐associated variants. Increased awareness and early genetic testing for ARC are suggested in cases with failure to thrive, renal tubular dysfunction, and rickets, even when the degree of cholestasis is mild. Prompt identification and intervention may improve the quality of life.

12 October 2026 in JPGN Reports
Verified
Journal Article
Open access
RHRachel E. Herdes
Rachel E. Herdes
LXLily Xia
Lily Xia
AAAtu Agawu
Atu Agawu
Arun AjmeraArun Ajmera
Arun Ajmera
MGMary Abigail S. Garcia
Mary Abigail S. Garcia
DDDeborah Duro
Deborah Duro
Introduction: Nutrition support teams (NSTs) were developed to standardize nutrition evaluation practices and coordinate transdisciplinary expertise for appropriate administration of inpatient nutritional care. Minimal data are available regarding the current practices, structure, and perceived utility of pediatric NSTs in diverse hospital systems. Methods: This was a cross‐sectional survey study disseminated electronically to three electronic listservs associated with the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN). Results: Forty‐seven unique responses were obtained. Sixty‐two percent reported a current NST at their institution. Of those with an NST, 97% reported reviewing parenteral nutrition (PN) orders, 90% recommended nutritional assessment modalities, 86% determined PN appropriateness, and 72% reviewed enteral nutrition orders. More than 50% of respondents strongly agreed that an NST improved patient safety, improved patient nutritional status, improved quality of care, decreased rates of malnutrition, and promoted interdisciplinary care. Among those without an NST, 33% of respondents reported that they were previously unsuccessful at developing an NST at their site. Perceived barriers to NST implementation in more than 50% of respondents were lack of protected time, budget or funding issues, lack of available staff, and lack of interdisciplinary support. Discussion: This study demonstrates heterogeneity of pediatric NSTs in North America with regard to frequency of services, while showing general consistency in the scope of services provided. It highlights the overall perceived benefit of NSTs. Financial compensation continues to be a barrier to access to NSTs with a notable percentage of NSTs reportedly not billing for services.

19 April 2024
Verified
Preprint
Open access
PDF file
RRRahiya Rehman
Rahiya Rehman
LGLeslia Gonzalez
Leslia Gonzalez
KKKelsey Kolbe
Kelsey Kolbe
WBWilliam Brucker
William Brucker
MFMohammed Faizan
Mohammed Faizan
CCCarolina Cerezo
Carolina Cerezo
Arthrogryposis, Renal dysfunction, Cholestasis (ARC) Syndrome with A Novel Mutation in two siblings